The study of Johnson & Johnson’s Covid-19 vaccine has been paused due to an unexplained illness in a study participant. A document sent to outside researchers running the 60,000-patient clinical trial states that a “pausing rule” has been met, that the online system used to enroll patients in the study has been closed, and that the…
Tag: Vaccine Trial
Daily Mail reports “Oxford and AstraZeneca’s COVID vaccine trial is put on HOLD as British volunteer has ‘serious’ reaction ‘that triggered spinal cord infection'”
Trials of Oxford University’s coronavirus vaccine have been put on hold after a British volunteer was rushed to hospital with suspected swelling in their spinal cord. UK drug giant AstraZeneca, which owns the rights to the vaccine, announced last night that all studies of the jab had been paused indefinitely while it investigates whether the…
NY Post reports “AstraZeneca halts COVID-19 vaccine trial after possible serious side effect”
Drug giant AstraZeneca has put its coronavirus-vaccine testing on hold after a study participant suffered a possible serious side effect, a report said Tuesday. The pharmaceutical manufacturer has been testing a potential vaccine it developed with the University of Oxford in Britain, and a UK participant’s suspected negative reaction to it prompted what the company called…
ACB raises concerns on GM Covid-19 vaccine trials for SA, calls for transparency & public hearings
African Centre for Biodiversity raises concerns over Covid vaccine trials proposed in South Africa. Regarding: Non-disclosure of vital safety data and information, which have been redacted as ‘confidential business information’ Lack of literature references throughout to substantiate health and ecosystem safety claims, making it difficult to evaluate some of the claims being made as to…
Business Insider report “The ex-pharma exec leading Trump’s COVID-19 vaccine program has $10 million in stock options for a company getting federal funding”
Dr Moncef Slaoui, former pharma exec and chief Scientist for Trump’s “Operation Warp Speed,” which aims to develop a working Covid-19 vaccine as fast as possible, has more than $10 million in stock options in one of the companies receiving federal funding. Described across four separate filings, Slaoui has 155,438 options in Moderna. The stake…
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Moderna, Inc. announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Regarding adverse effects: “To date, the most notable adverse events were seen at the 250 µg dose level, comprising…